We are live on ! Find out more
ALXO icon

ALX Oncology
ALXO

57 hedge funds and large institutions have $1.03B invested in ALX Oncology in 2020 Q3 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

73.71% more ownership

Funds ownership: 0% → 73.71% (+74%)

Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
1.15%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VP
venBio Partners
California
+$381M
2
VC
Vivo Capital
California
+$166M
3
LGM
Logos Global Management
California
+$123M
4
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
+$56.9M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$40.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VP
1
venBio Partners
California
$366M +$381M +9,699,925 New
VC
2
Vivo Capital
California
$159M +$166M +4,220,048 New
LGM
3
Logos Global Management
California
$118M +$123M +3,136,981 New
BOTOTLSJU
4
Board of Trustees of The Leland Stanford Junior University
California
$54.6M +$56.9M +1,446,854 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$39M +$40.7M +1,034,528 New
FCMI
6
Foresite Capital Management IV
California
$36.7M +$38.3M +973,514 New
CAM
7
Cormorant Asset Management
Massachusetts
$36M +$38.2M +971,770 New
BlackRock
8
BlackRock
New York
$31.3M +$32.6M +829,014 New
Fidelity Investments
9
Fidelity Investments
Massachusetts
$28.3M +$29.4M +748,830 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$24.4M +$25.4M +645,382 New
BI
11
BVF Inc
California
$24.1M +$25.1M +638,928 New
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$16.2M +$16.9M +429,802 New
RG
13
Redmile Group
California
$15.4M +$16M +407,400 New
Capital World Investors
14
Capital World Investors
California
$11.3M +$11.8M +300,000 New
VA
15
VR Adviser
New York
$11.3M +$11.8M +300,000 New
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$8.44M +$8.79M +223,654 New
Franklin Resources
17
Franklin Resources
California
$7.55M +$7.86M +200,000 New
SFM
18
Sphera Funds Management
Israel
$6.87M +$7.16M +182,070 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$5.83M +$6.08M +154,629 New
Northern Trust
20
Northern Trust
Illinois
$4.37M +$4.55M +115,816 New
State Street
21
State Street
Massachusetts
$4.28M +$4.46M +113,523 New
AG
22
Artal Group
Luxembourg
$3.77M +$3.93M +100,000 New
Axa
23
Axa
France
$2.83M +$2.94M +74,851 New
Charles Schwab
24
Charles Schwab
California
$2.19M +$2.28M +57,924 New
N
25
Nuveen
North Carolina
$1.36M +$1.41M +35,908 New
1
2 3

ALXO Hedge Fund Activity: Q3 2020 in Review

57 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q3 2020, worth a combined $1.03B.

Buyers outnumbered sellers: 57 funds opened new ALXO positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was venBio Partners, opening a new position worth an estimated $381M.

  • 57 institutional investors held ALX Oncology (ALXO) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $1.03B of ALX Oncology stock for Q3 2020.
  • 57 funds opened new ALX Oncology positions in Q3 2020 and 0 closed out, a net change of +57 holders.
  • The largest ALX Oncology buyer in Q3 2020 was venBio Partners, an estimated $381M added.

Based on aggregated 13F filings for Q3 2020.